A new study’s findings contradict previous assumptions about IVF and breast cancer risk.
Breast Cancer
Latest News
Advertisement
CME Content
Advertisement
Top news of the day from across the health care landscape.
Mouse models of paclitaxel lower than clinical doses showed an increase of liver metastases.
Nanostructured lipid carriers filled with melatonin may boost chemotherapy efficacy.
Approximately 38% of women who had initial echocardiograms received a follow-up scan.
Proteogenomic analysis expands knowledge into breast cancer therapy.
Hops could lower risk of breast cancer in post-menopausal women.
Female mice with obese fathers have delayed development in breast tissue and higher rates of breast cancer.
Both patients with aggressive and non-aggressive ductal carcinoma in situ receive the same treatment.
UM-164 blocks the c-Src kinase that plays a role in the growth and spread of breast cancer.
After breast cancer surgery, patients who received non-opiate analgesia used less painkilling medication than patients who received opiate analgesia.
Genetic changes to BRCA1 predicts higher risk of breast and ovarian cancers.
Treating modifiable risk factors could enhance breast cancer prevention.
Top news of the day from across the healthcare landscape.
Top news of the day from across the health care landscape.
Breast cancer cells found to hide in bone marrow before resurging.
Researchers were able to better predict the risk of developing breast cancer.
The protein GlyRS helps modify proteins that cause cancer growth.
Doxorubicin, all-trans retinoic acid, and entinostat significantly reduced triple-negative breast cancer tumors in mice.
Postmenopausal patients with invasive ductal carcinomas had high levels of saturated fats.
Researchers find indicators of poor chemotherapy response.
Women older than age 65 face higher risk for several comorbidities from breast cancer treatment.
Uncialamycin may effectively treat various cancer types, including gastric, lung, and ovarian cancers.
The drug eCF506 can selectively block the Src tyrosine kinase and stop the growth of breast cancer cells.
Rapalink able to inhibit growth in drug-resistant tumors across different cancer types.
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves First OTC Acetaminophen–Naproxen Combination for 12-Hour Pain Relief
2
FDA Approves Furosemide Autoinjector for Treatment of Edema in CKD or Heart Failure
3
What Real-World Data Show About Moving Patients From Humira to Biosimilars
4
Q&A: Pharmacists' Role in CKD Grows as Finerenone Eyes Label Expansion
5